Catalyst Wire Dossier Catalyst Wire Dossier

Trivalent recombinant hemagglutinin influenza vaccine

trivalent recombinant hemagglutinin influenza vaccine · National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trivalent recombinant hemagglutinin influenza vaccine, covering 2011-08-12 to 2011-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Trivalent rHA Dose Escalation Study in Elderly Subjects [Phase 2]

See pricing